de Oliveira CEC, Oda JMM, Guembarovski RL, et al. CC chemokine receptor 5: the interface of host immunity
and cancer. Dis Markers. 2014;2014:126954. doi:10.1155/2014/126954.
Lesokhin AM, Hohl TM, Kitano S, et al. Monocytic CCR2+ myeloid-derived suppressor cells promote immune
escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment. Cancer Res.
2012;72(4):876-886.
Lim HW, Lee J, Hillsamer P, Kim CH. Human Th17 cells share major trafficking receptors with both polarized
effector T cells and FOXP3+ regulatory T cells. J Immunol. 2008;180(1):122-129.
Mack M, Cihak J, Simonis C, et al. Expression and characterization of the chemokine receptors CCR2 and CCR5
in mice. J Immunol. 2001;166(7):4697-4704.
Sica A, Saccani A, Bottazzi B, et al. Defective expression of the monocyte chemotactic protein-1 receptor
CCR2 in macrophages associated with human ovarian carcinoma. J Immunol. 2000;164(2):733-738.
Umansky V, Blattner C, Gebhardt C, Utikal J. CCR5 in recruitment and activation of myeloid-derived
suppressor cells in melanoma. Cancer Immunol Immunother. 2017;66(8):1015-1023.
Weitzenfeld P, Ben-Baruch A. The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets
for personalized therapy in cancer. Cancer Lett. 2014;352(1):36-53.
Huang B, Lei Z, Zhao J, et al. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to
cancers. Cancer Lett. 2007;252(1):86-92.
Lim SY, Yuzhalin AE, Gordon-Weeks AN, Muschel RJ. Targeting the CCL2-CCR2 signaling axis in cancer
metastasis. Oncotarget. 2016;7(19):28697-28710.
Chang L-Y, Lin Y-C, Mahalingam J, et al. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of
CD8+ T cells in colon cancer by T-regulatory cells. Cancer Res. 2012;72(5):1092-1102.
Sanford DE, Belt BA, Panni RZ, et al. Inflammatory monocyte mobilization decreases patient survival in
pancreatic cancer: a role for targeting the CCL2/CCR2 axis. Clin Cancer Res. 2013;19(13):3404-3415.
Franklin RA, Liao W, Sarkar A, et al. The cellular and molecular origin of tumor-associated macrophages.
Science. 2014;344(6186):921-925.
Loberg RD, Ying C, Craig M, Yan L, Snyder LA, Pienta KJ. CCL2 as an important mediator of prostate cancer
growth in vivo through the regulation of macrophage infiltration. Neoplasia. 2007;9(7):556-562.
Wolf MJ, Hoos A, Bauer J, et al. Endothelial CCR2 signaling induced by colon carcinoma cells enables
extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell. 2012;22(1):91-105.
Tan MCB, Goedegebuure PS, Belt BA, et al. Disruption of CCR5-dependent homing of regulatory T cells
inhibits tumor growth in a murine model of pancreatic cancer. J Immunol. 2009;182(3):1746-1755.
Kitamura T, Qian B-Z, Soong D, et al. CCL2-induced chemokine cascade promotes breast cancer metastasis by
enhancing retention of metastasis-associated macrophages. J Exp Med. 2015;212(7):1043-1059.
Lefebvre E, Moyle G, Reshef R, et al. Antifibrotic effects of the dual CCR2/CCR5 antagonist cenicriviroc in
animal models of liver and kidney fibrosis. PLoS One. 2016;11(6):e0158156. doi:10.1371/journal.pone.0158156.